Eastern Virginia Medical School is a public medical school in Norfolk, Virginia. Founded by grassroots efforts in the Southeastern part of Virginia known as Hampton Roads, EVMS is not affiliated with an undergraduate institution and coordinates training through multiple medical centers in the Hampton Roads region.

During the past decade, Eastern Virginia Medical School conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 31 clinical trials were completed, i.e. on average, 54.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 19 clinical trials were completed. i.e. 73.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eastern Virginia Medical School" #1 sponsor was "CONRAD" with 10 trials, followed by "Eastern Virginia Medical School" with 9 trials sponsored, "Health Decisions" with 9 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "NSABP Foundation Inc" with 9 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastern Virginia Medical School" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 12 trials as a collaborator, "Eastern Virginia Medical School" with 7 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Eastern Virginia Medical School" are "Contraception" (11 trials), "Breast Cancer" (7 trials), "Chronic Rhinosinusitis" (4 trials), "Diabetic Neuropathy, Painful" (4 trials) and "Female Contraception" (3 trials). Many other conditions were trialed in "Eastern Virginia Medical School" in a lesser frequency.

Most popular intervention types in "Eastern Virginia Medical School" are "Drug" (75 trials), "Device" (19 trials), "Other" (14 trials), "Procedure" (12 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "cisplatin" (4 trials), "placebo" (4 trials), "cyclophosphamide" (3 trials) and "gemcitabine hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Eastern Virginia Medical School" are 61 trials for "All" genders, 59 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Eastern Virginia Medical School". 1 are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in Eastern Virginia Medical School, 2 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Eastern Virginia Medical School, 10 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 20 trials that are defined as “Not Applicable".

Eastern Virginia Medical School has several departments that took part in Clinical trials: "Eastern Virgnia Medical School, Strelitz Diabetes Center" - 7 trials, "Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School" - 2 trials, "Children's Hospital of the King's Daughters/East Virginia Medical School" - 2 trials, "Eastern Virginia Medical School Strelitz Diabetes Center" - 2 trials, "The Glennan Center for Geriatrics & Gerontology, Eastern Virginia Medical School" - 2 trials, "EVMS Sleep Medicine" - 2 trials, "Eastern Virginia Med. School, Ctr. for the Comprehensive Care of Immune Deficiency CRS" - 2 trials